Schizophrenia News and Research

Latest Schizophrenia News and Research

Variation in 3 genes influences risk of age-related macular degeneration

Researchers in Boston have discovered a new common, noncoding variant in the Complement Factor H (CFH) gene that is associated with age-related macular degeneration (AMD), the leading cause of irreversible visual impairment and blindness among persons aged 60 and older.

30 Aug 2006

The public face of mental illness

Both the tabloid and the broadsheet press have consistently given disproportionate and sensationalized coverage to psychotic illnesses such as schizophrenia, often linking them to serious crime.

30 Aug 2006

RNA gene found to be one of the fastest evolving regions in human genome

Since completing the sequencing of the chimpanzee genome last year, geneticists have spent many hours comparing human DNA sequences to those of our closest evolutionary relative, looking for the differences that distinguish the two species.

16 Aug 2006

New understanding of how our brains process sensory information

The same chemical in the body that is targeted by the drug Viagra. also helps our brains "boot up" in the morning so we can process sights, sound, touch and other sensory information.

8 Aug 2006

Researchers have found that increasing paternal age is significantly associated with increased rates of spontaneous abortion

Results indicate that as the male partner ages there is a steady increase in rate of miscarriage.

3 Aug 2006

Genetic mutations may be responsible for schizophrenia

The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.

2 Aug 2006

fMRI shows "gambling" structures in the brain

From gamblers playing blackjack to investors picking stocks, humans make a wide range of decisions that require gauging risk versus reward.

2 Aug 2006

Researchers identify earliest neuron in the embryonic human cerebral cortex

Researchers at Yale School of Medicine and the University of Oxford have identified the very first neurons in what develops into the cerebral cortex, the part of the brain that makes humans human.

24 Jul 2006

Memory Pharmaceuticals achieves milestone for the treatment of neurological and psychiatric disorders

Memory Pharmaceuticals is to receive approximately $2.3M in funding from Roche in 2007.

17 Jul 2006

Clozapine has serious health consequences

Patients who take clozapine, the most effective antipsychotic drug, have significantly higher rates of metabolic syndrome, according to a first-of-a-kind study by University of Rochester Medical Center researchers.

3 Jul 2006

Altered activity in receptor pair points to further complexity in schizophrenia pathology

Researchers at the University of Pennsylvania School of Medicine, in collaboration with scientists at the City University of New York, have identified a striking dysregulation in neuronal receptor activity in the postmortem brain tissue from patients with schizophrenia.

18 Jun 2006

Antipsychotic use in children increasing

A steadily increasing number of patients younger than age 20 received prescriptions for antipsychotic medications between 1993 and 2002, according to a report published in the June issue of Archives of General Psychiatry.

9 Jun 2006

Protein called Elk-1appears to play role in neurodegeneration and schizophrenia

Pprotein called Elk-1 interacts with mitochondria, the energy storehouse of a cell, suggesting that this protein - typically active in the nucleus - could play a role in cell death and mitochondria-related diseases such as neurodegeneration and schizophrenia.

9 Jun 2006

PET imaging of cerebral cannabinoid CB1 receptors with [11C]JHU75528

A team of Johns Hopkins researchers developed a new radiotracer - a radioactive substance that can be traced in the body - to visualize and quantify the brain's cannabinoid receptors by positron emission tomography (PET).

6 Jun 2006

New research on brain, hormones and behavior

New clinical and basic science research findings focusing on the interaction between hormones and the brain and its influence on behavior will be presented for the first time at the 6th International Congress of Neuroendocrinology.

6 Jun 2006

Bipolar disorder causes children to misinterpret facial expressions

Researchers at the National Institute of Mental Health (NIMH) have discovered why children with bipolar disorder tend to be more aggressive and irritable and have poorer social skills than healthy children.

31 May 2006

Extension of embryo screening will help reduce serious illness

A fertility watchdog in Britain, the Human Fertilisation and Embryology Authority (HFEA), has given approval for the extension of embryo screening to cover a wider range of mutated genes, in the main those which raise the risk of cancer in later life.

11 May 2006

Lilly to extend patient assistance programs for Medicare patients

Eli Lilly and Company has announced that it will be extending its existing patient assistance program, LillyAnswers, through the end of this year to qualifying patients currently participating in the program, to help bridge the gap in coverage for people who need Lilly medicines, but are not yet enrolled in Medicare Part D.

11 May 2006

Olanzapine appears to lower or delay full-blown psychosis

For young people who clearly seem to be developing early signs of schizophrenia, treatment with the antipsychotic drug olanzapine appears to lower or delay the rate of conversion to full-blown psychosis, according to an article by a Yale School of Medicine researcher in the May issue of The American Journal of Psychiatry.

3 May 2006

Study indicates how drug efficacy can be increased by manipulating the signalling mechanism

Researchers believe they have found a way to change the action of 60 percent of currently available medications, in some cases making them many times more effective, according to an article published in the April 21 edition of the journal Science. The discovery has the potential to improve treatments for diseases including heart disease, cancer, diabetes, depression and arthritis. The study describes a new way to manipulate perhaps the most important signaling mechanism in human cells: G-protein coupled receptors (GPCRs).

28 Apr 2006